Industry News
Anatara preps manufacturing for Detach trial
Anatara Lifesciences is taking steps towards registration with the AVPMA for non-antibiotic diarrhoea treatment Detach, initiating the manufacturing process for Australian trials in pigs.
[ + ]ATSE elects 2014 Fellows
The Australian Academy of Technological Sciences and Engineering (ATSE) has elected 25 new Fellows for 2014. The academy is an independent body of 800 eminent scientists and engineers seeking to enhance Australia's prosperity through technological innovation.
[ + ]Koala transcriptome revealed
A blueprint for the koala genome has been sequenced, with researchers transcribing 15,000 koala genes.
[ + ]Link between viral infection and autoimmune disease
Australian scientists have discovered that common viral infections can pave the way to autoimmune disease. [ + ]
Ramaciotti Foundations award $1m for biomedical research
The Clive and Vera Ramaciotti Foundations are awarding $1,022,458 to biomedical research through the distribution of the annual Ramaciotti Medal for Excellence in Biomedical Research and 13 establishment grants. [ + ]
Starpharma cancer drug shows good PK profile
Starpharma (ASX:SPL) said preliminary analysis of the pharmacokinetic profile of DEP-docetaxel shows superior duration of exposure compared to the reference drug.
[ + ]Malaria is shaping the human genome
Researchers from the Malaria Genomic Epidemiology Network have found that malaria has been a major force of evolutionary selection on the human genome. Small genetic changes have resulted in improved survival against malaria, and children carrying these genes have a better chance of passing them on. [ + ]
A breath test for dolphins
US engineers have developed a new device for collecting dolphin breath for analysis, which could make it easier to check the animals' health. [ + ]
Oncology conference to tackle ethical dilemmas
Health research ethics organisation Bellberry is hosting a congress to discuss some of the ethical dilemmas seen in cancer trials, including access to new treatments for both research participants and later to the wider community. [ + ]
Randox aspirin-resistance test gets TGA tick
The TGA has approved a Randox Laboratories test to help measure aspirin resistance in patients taking the drug to reduce heart attack risk.
[ + ]New board directors for RIRDC
Minister for Agriculture Barnaby Joyce has announced the appointment of six new non-executive directors to the board of the Rural Industries R&D Corporation (RIRDC). [ + ]
Anatara Lifesciences trading on ASX
Anatara Lifesciences (ASX:ANR) has started trading on the ASX, after conducting a $7m IPO to raise funds to commercialise its non-antibiotic diarrhoea treatment.
[ + ]Academy responds to competitiveness agenda
The Australian Government this week announced its Industry Innovation and Competitiveness Agenda, described as a plan for a strong and competitive economy. The agenda and its initiatives have drawn the interest of the Australian Academy of Science. [ + ]
Prima's M&A target lines up AU cancer patent
Prima BioMed (ASX:PRR) has announced that Immutep, the cancer immunotherapy company it has proposed to acquire, will be receiving an Australian patent covering its technology.
[ + ]Academy forms cell and developmental biology committee
The National Committee for Cellular and Developmental Biology has been formed at the Australian Academy of Science.
[ + ]
